A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2009
11/19/2009	WO2009138165A1 Sgc stimulators, sgc activators and combinations thereof for the treatment of hearing impairment
11/19/2009	WO2009116524A9 Modified protein
11/19/2009	WO2009108577A3 Use of black soybean for treating ophthalmic diseases
11/19/2009	US20090286868 2-Amino-2-oxoethyl trans-3-[5-(naphth-1-yl)-1,3-dioxan-2-yl]propyl carbamate; reacting the phenylcarbonate with 2-aminodioxane; fatty acid amido hydrolase (FAAH) inhibitors; analgesics; nervous system disorders; gastrointestinal disorders,; to name just a few
11/19/2009	US20090286786 Compounds having a 4-pyridylalkylthio group as a substituent
11/19/2009	US20090286773 Kinase inhibitors
11/19/2009	US20090286743 Methods and Compositions for Treating Conditions of the Eye
11/19/2009	US20090286736 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)
11/19/2009	US20090286734 Pharmaceutical Use of Alpha Antigen or Alpha Antigen Gene
11/19/2009	US20090286718 Stable Aqueous Cyclosporin Compositions
11/19/2009	US20090285816 Albumin Fusion Proteins
11/19/2009	CA2725235A1 Sgc stimulators, sgc activators and combinations thereof for the treatment of hearing impairment
11/19/2009	CA2724435A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof
11/19/2009	CA2724293A1 Quinolynylmethylimidizoles as therapeutic agents
11/19/2009	CA2724271A1 Therapeutic substituted cyclopentanes
11/19/2009	CA2724055A1 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2 -dihydroquinoline derivatives having substituted oxy group
11/19/2009	CA2724052A1 Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion
11/19/2009	CA2723458A1 Controlled release corticosteroid compositions and methods for the treatment of otic disorders
11/18/2009	EP2119716A1 Aza-bridged-ring compound
11/18/2009	EP2119702A1 Amide derivative
11/18/2009	EP2119440A1 Amidino derivatives for use in the prevention or treatment of retinitis pigmentosa and Leber's disease
11/18/2009	EP2119439A2 Angiogenesis inhibitor for treating macular degeneration
11/18/2009	EP2119436A1 Pharmaceutical compositions for preventing and treating eye pathologies
11/18/2009	EP2118094A1 Gamma-lactams for the treatment of glaucoma or elevated intraocular pressure
11/18/2009	EP2117553A2 Compositions and methods for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory track
11/18/2009	EP1817033B1 Treatment of inflammatory bowel disease
11/18/2009	EP1744736B1 Method of treating dry eye disorders and uveitis
11/18/2009	EP1490064B1 Substituted pyridinones as modulators of p38 map kinase
11/18/2009	EP1280781B1 5-ht 7 receptor antagonists
11/18/2009	EP1218354B1 Quinazoline derivatives and their use as pharmaceuticals
11/18/2009	EP0957901B1 Pharmaceutical preparations of glutathione and methods of administration thereof
11/18/2009	EP0760811B1 Imidazole derivatives as histamine receptor h3 modulators
11/18/2009	CN101583377A Treatment of fibrosis
11/18/2009	CN101583351A Nutritional supplement composition for treatment of ocular diseases
11/18/2009	CN101579498A Ready-to-use zedoary turmeric oil ophthalmic gel
11/18/2009	CN101579488A Chinese medicament for treating cataract and glaucoma
11/18/2009	CN101579456A Medicine for treating otitis media and preparation method thereof
11/18/2009	CN101579433A Houttuynia-honeysuckle ophthalmic instant-type gel and preparation method thereof
11/18/2009	CN101579431A Ready-to-use herba houttuyniae ophthalmic gel
11/18/2009	CN101579403A Ready-to-use Dactylicapnos scandens ophthalmic gel
11/18/2009	CN101579402A Ready-to-use decumbent corydalis tuber ophthalmic gel
11/18/2009	CN101579393A Traditional Chinese medicine ophthalmic preparation and preparation technology thereof
11/18/2009	CN101579363A Traditional Chinese medicine ophthalmic preparation and preparation method thereof
11/18/2009	CN101579358A Ready-to-use traditional Chinese medicine ophthalmic gel
11/18/2009	CN101579357A Ready-to-use fel ursi ophthalmic gel
11/18/2009	CN101579305A Ready-to-use puerarin ophthalmic gel
11/18/2009	CN100560589C Imidazoselenazole compounds and their use for prevention and/or treatment of diseases relative to protein aging
11/18/2009	CN100560578C Plant extracts for preventing eye fatigue and their preparation and preparing method
11/18/2009	CN100560084C Method and preparations having effect against allergic symptoms
11/18/2009	CN100560055C Ophthalmic gel and its preparation method
11/17/2009	US7619100 Physiologically active substances
11/17/2009	US7618994 Such as (+/-)-[9-(4-chlorobenzyl)-6-fluoro-8-methanesulfonyl-2, 3,4,9-tetrahydro-1H-carbazol-1-yl]acetic acid; prostaglandin receptor antagonists; antihistamines; nasal decongestion, rhinitis
11/17/2009	US7618961 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia
11/17/2009	US7618643 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
11/17/2009	US7618634 Neurotoxic oligomers
11/17/2009	US7618629 Manipulation of cytokine levels using CD83 gene products
11/17/2009	US7618621 Preparing culture of pluripotent brain tissue for nervous tissue regeneration, tissue engineering and treating nervous system disorders
11/17/2009	US7618619 For use in ocular surgery; containing a vital dyes, especially a disazo dye, that does not diffuse out of the visco-elastic composition.
11/17/2009	CA2522051C Diamine derivative, production process therefor and antioxidant
11/17/2009	CA2411368C Therapeutic combinations of fatty acids
11/17/2009	CA2393809C Heterocyclic dihydropyrimidines as potassium channel inhibitors
11/17/2009	CA2374158C Indole derivatives
11/17/2009	CA2369997C Compositions and methods for treating amyloidosis
11/17/2009	CA2336822C Method of treatment and pharmaceutical composition
11/17/2009	CA2321198C 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
11/12/2009	WO2009137681A1 Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
11/12/2009	WO2009137544A1 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds
11/12/2009	WO2009137413A1 Therapeutic cyclopentane derivatives
11/12/2009	WO2009137345A1 Therapeutic compounds
11/12/2009	WO2009137343A1 Therapeutic substituted hydantoins, and related compounds
11/12/2009	WO2009137342A1 Therapeutically useful substituted 1, 7-diphenyl-l, 2, 3, 5, 6, 7-hexahydropyrido [ 3, 2, 1-i j ] quinoline compounds
11/12/2009	WO2009137303A2 Use of extracts of capraria biflora in the prevention and/or treatment of senile cataracts
11/12/2009	WO2009137085A2 Sustained release delivery of active agents to treat glaucoma and ocular hypertension
11/12/2009	WO2009136611A1 Glutathione production enhancer, prophylactic/therapeutic agent for diseases associated with lack of glutathione, and food, beverage and feed
11/12/2009	WO2009136599A1 Non-covalent crosslinking agent for collagen
11/12/2009	WO2009136396A2 Sulfobetaines for therapy
11/12/2009	WO2009136281A1 Nitric oxide donating prostamides
11/12/2009	WO2009117467A3 Therapeutic compounds
11/12/2009	WO2009105756A3 Protection of neural retina by reduction of rod metabolism
11/12/2009	WO2008139261A9 Omega-3 lipid compound
11/12/2009	US20090281184 Pharmaceutical for prevention and treatment of ophthalmic disease induced by in-crease in vasopermeability
11/12/2009	US20090281164 RNA INTERFERENCE MEDIATED INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/12/2009	US20090281154 Ophthalmic Compositions for Treating Ocular Hypertension
11/12/2009	US20090281149 Amine Derivative Compounds for Treating Ophthalmic Diseases and Disorders
11/12/2009	US20090281147 Method of treating of demyelinating diseases or conditions
11/12/2009	US20090281130 Quinazoline derivatives
11/12/2009	US20090281030 Genes Associated with Macular Degeneration
11/12/2009	US20090280204 Use of extracts of capraria biflora in the prevention and/or treatment of senile cataracts
11/12/2009	US20090280158 Sustained release delivery of active agents to treat glaucoma and ocular hypertension
11/12/2009	CA2728229A1 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds
11/12/2009	CA2728227A1 Therapeutic cyclopentane derivatives
11/12/2009	CA2724972A1 Therapeutic compounds
11/12/2009	CA2723894A1 Therapeutic substituted hydantoins, and related compounds
11/12/2009	CA2723893A1 Therapeutic n-aryl or n-heteroaryl pyrazolidine and pyrazolidinone derivatives
11/12/2009	CA2723798A1 Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
11/12/2009	CA2723775A1 Therapeutically useful substituted 1,7-diphenyl-1,2,3,5,6,7-hexahydropyrido[3,2,1-ij]quinoline compounds
11/12/2009	CA2723704A1 Nitric oxide donating prostamides
11/12/2009	CA2723440A1 Sulfobetaines for therapy
11/12/2009	CA2722971A1 Sustained release delivery of active agents to treat glaucoma and ocular hypertension
11/11/2009	EP2116263A1 Reversibly light-switchable drug-conjugates

1 ... 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 ... 531